MED

Business Context and Reporting Period

Company: Medifast, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2009
Business Overview: Medifast produces, distributes, and sells weight management and disease management products, primarily meal replacements and supplements. Operations are conducted through five wholly-owned subsidiaries. The company utilizes a multi-channel distribution strategy including direct-to-consumer (Medifast Direct), direct selling (Take Shape for Life), physician networks, and brick-and-mortar clinics (Medifast Weight Control Centers).

Key Financial Metrics (2009)

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased 57% year-over-year, driven primarily by the Take Shape for Life (TSFL) division, which grew 101% to $100.4 million. The Medifast Weight Control Centers division grew 93%.
• Profitability: Net income surged 147% to $12.0 million. Operating income more than doubled to $19.4 million.
• Advertising Efficiency: The company achieved a 2.7 to 1 return on advertising spend in 2009 (up from 2.5 to 1 in 2008) while reducing total advertising spend by $400,000.
• Restatement of Prior Years: The company restated financial results for 2006, 2007, and 2008 due to an error in the calculation of deferred tax liabilities under SFAS No. 109. The error involved failing to record deferred tax liabilities for timing differences between financial reporting depreciation and accelerated tax depreciation. This restatement reduced prior years' net income but had no effect on 2009 revenues, operating income, or cash flows.

Guidance, Outlook, and Risks

Management Commentary and Outlook

• Expansion Plans: Management anticipates opening 13-15 new corporately owned Medifast Weight Control Centers in 2010.
• Product Development: New product lines introduced in 2009 include Pretzel Sticks, Cheese Puffs, and Essential 1 Digestive Health supplements.
• Seasonality: The company noted a decrease in traditional seasonality (typically weak in Nov/Dec) due to increased consumer awareness of health benefits and the growth of the TSFL division.
• Tax Rate: The company anticipates an effective tax rate of approximately 39-40% in 2010.

Risks and Contingencies

• Internal Control Material Weakness: The company identified a material weakness in internal controls over financial reporting related to the preparation and review of the income tax provision. This led to the restatement of prior years. Remediation includes hiring an in-house CPA with SFAS 109 expertise and engaging an outside tax advisor for quarterly reviews.
• Legal Proceedings: Medifast filed a civil complaint in February 2010 against Barry Minkow and others for defamation and market manipulation, seeking at least $270 million in damages. The company also faces an adversary proceeding in bankruptcy court regarding alleged preferential payments, which it disputes.
• Operational Risks: Risks include reliance on advertising effectiveness, potential health-related claims, competition from fad diets or pharmaceuticals, and the ability to manage rapid growth without infrastructure strain.

Investor Verification Checklist

• Restatement Impact: Verify the specific adjustments made to 2006-2008 financial statements in Footnote 17 to understand the full scope of the accounting error.
• Internal Controls: Review the progress of remediation efforts regarding the material weakness in tax provision calculations to ensure future reporting reliability.
• Legal Exposure: Monitor the status of the $270 million defamation lawsuit against Barry Minkow and the bankruptcy adversary proceeding.
• TSFL Growth Sustainability: Assess the retention rates and productivity of the 76% increase in active health coaches to ensure the 101% revenue growth in this segment is sustainable.
• Cash Flow vs. Debt: Confirm that the $12.7 million cash position is sufficient to fund the planned expansion of 13-15 new clinics and ongoing capital expenditures without requiring significant new debt.